Researcher Profile

Im, Joo-Young image
Im, Joo-Young(임주영) 59

Biotherapeutics Translational Research Center (바이오신약중개연구센터)

Keywords Cloud

KRIBB Co-Working

Results 1-20 of 59 (Search time: 0.001 seconds).

No. Year Title Type
59 2025

2025Patent

세포 내 존재 단백질과 세포 외부로 분비되는 단백질을 동시 발현하는 이중 발현벡터를 포함하는 암의 예방 또는 치료용 조성물JP2023-559785 (2023.09.25) / 7649014 (2025.03.11)원미선; 임주영
Patent
58 2025

2025Article

VHL-mediated SYT11 degradation suppresses gastric cancer cell growth and invasion through downregulation of SPINK1Journal of Cellular and Molecular Medicine, vol. 29, no. 13, pp. e70658-e70658Ji Su Yu; Mi Aie Hwang; Mi Sun Won; Joo-Young Im; D H Kweon; Y G Park; Bo Kyung Kim
Article
57 2025

2025Research Project

막수용체 유전자군 조절을 통한 난치암 동반진단 항암제 개발 = Development of Targeted Cancer Drugs with Companion Diagnostics based on Regulation of G-protein Coupled Receptor Targetome연구책임자 : 반현승 / 사업기간 : 2025.01.01 ~ 2025.12.31
Research Project
56 2025

2025Research Project

폐암 저산소 미세환경 조절 기반 GPCR 표적 대사항암제 연구 = Hypoxia-associated GPCRs regulating lung cancer metabolism연구책임자 : 반현승 / 사업기간 : 2025.03.01 ~ 2026.02.28
Research Project
55 2024

2024Research Project

바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2024.01.01 ~ 2024.12.31
Research Project
54 2024

2024Research Project

막수용체 유전자군 조절을 통한 난치암 동반진단 항암제 개발 = Development of Targeted Cancer Drugs with Companion Diagnostics based on Regulation of G-protein Coupled Receptor Targetome연구책임자 : 반현승 / 사업기간 : 2024.01.01 ~ 2024.12.31
Research Project
53 2024

2024Research Project

재발성 및 불응성 다발성골수종 치료를 위한 19S RP UCHL5 저해 화합물 개발 = Development of 19S RP UCHL5 inhibitors for the treatment of relapsed and refractory multiple myeloma연구책임자 : 반현승 / 사업기간 : 2024.01.01 ~ 2024.07.31
Research Project
52 2024

2024Research Project

폐암 저산소 미세환경 조절 기반 GPCR 표적 대사항암제 연구 = Hypoxia-associated GPCRs regulating lung cancer metabolism연구책임자 : 반현승 / 사업기간 : 2024.03.01 ~ 2025.02.28
Research Project
51 2024

2024Article

CYB5R3 functions as a tumor suppressor by inducing ER stress-mediated apoptosis in lung cancer cells via the PERK-ATF4 and IRE1α-JNK pathwaysExperimental and Molecular Medicine, vol. 56, no. 1, pp. 235-249Joo-Young Im; S J Kim; Jong Lyul Park; Tae Hee Han; Woo-Il Kim; Inhyub Kim; Bomin Ko; So-Young Chun; Mi-Jung KangBo Kyung Kim, et al.
Article
50 2023

2023Patent

DDIAS 억제제 및 사멸 수용체 리간드를 포함하는 암의 예방 또는 치료용 조성물KR10-2017-0115249 (2017.09.08) / 10-2532779 (2023.05.10)원미선; 임주영김보경반현승
Patent
49 2023

2023Article

TNF-α secreted from macrophages increases the expression of prometastatic integrin αV in gastric cancerInternational Journal of Molecular Sciences, vol. 24, no. 1, pp. 376-376Mi Aie Hwang; Misun Won; Joo-Young ImMi-Jung Kang; D H Kweon; Bo Kyung Kim
Article
48 2023

2023Research Project

바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2023.01.01 ~ 2023.12.31
Research Project
47 2023

2023Research Project

MDH 저해제를 활용한 LKB1/KRAS-매개하는 암대사 조절 기전 연구 = Study on the LKB1/KRAS-mediated regulation of cancer metabolism using MDH inhibitor연구책임자 : 원미선 / 사업기간 : 2023.03.01 ~ 2024.02.13
Research Project
46 2023

2023Article

Design, synthesis and biological evaluation of novel MDH inhibitors targeting tumor microenvironmentPharmaceuticals, vol. 16, no. 5, pp. 683-683S Godesi; Jeong-Ran Han; Jang Keun Kim; D I Kwak; J Lee; H Nada; M Kim; Hyun A Yang; Joo-Young ImHyun Seung Ban, et al.
Article
45 2023

2023Article

DDIAS, DNA damage-induced apoptosis suppressor, is a potential therapeutic target in cancerExperimental and Molecular Medicine, vol. 55, no. 5, pp. 879-885Joo-Young ImMi-Jung KangBo Kyung Kim; Mi Sun Won
Article
44 2023

2023Research Project

암 치료 타겟 SYT11의 저해 물질 발굴연구책임자 : 김보경 / 사업기간 : 2023.06.01 ~ 2025.05.31
Research Project
43 2022

2022Patent

세포 내 존재 단백질과 세포 외부로 분비되는 단백질을 동시 발현하는 이중 발현벡터를 포함하는 암의 예방 또는 치료용 조성물KR10-2021-0039575 (2021.03.26) / 10-2393402 (2022.04.27)원미선; 임주영
Patent
42 2022

2022Article

Synaptotagmin 11 scaffolds MKK7-JNK signaling process to promote stem-like molecular subtype gastric cancer oncogenesisJournal of Experimental & Clinical Cancer Research, vol. 41, pp. 212-212Bo Kyung Kim; Da Mi Kim; Hyunkyung Park; Seon-Kyu Kim; Mi Aie Hwang; Jungwoon LeeMi-Jung Kang; Jae Eun Byun; Joo-Young ImMinho Kang, et al.
Article
41 2022

2022Research Project

바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2022.01.01 ~ 2022.12.31
Research Project
40 2022

2022Research Project

MDH 저해제를 활용한 LKB1/KRAS-매개하는 암대사 조절 기전 연구 = Study on the LKB1/KRAS-mediated regulation of cancer metabolism using MDH inhibitor연구책임자 : 원미선 / 사업기간 : 2022.03.01 ~ 2023.02.28
Research Project
1 2 3